Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen
Clinical trial NCT00514514 · COMPLETED
Trial details
- NCT number
- NCT00514514
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2015-06-01
- Enrollment
- 802
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.